Home / Compliance actions / 473486

FDA Warning Letter — Frontida BioPharm Inc

Case 473486 — FEI 2523348

The FDA took a Warning Letter action against Frontida BioPharm Inc on Aug 15, 2016 (Philadelphia, PA). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.

Action Details

Facility
Frontida BioPharm Inc
Date
Aug 15, 2016
Fiscal Year
2016
Product Type
Drugs
Center
CDER
Location
Philadelphia, PA (United States)

Facility

Recent inspections

FDA data resources

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.